$ATOS
Comments
-
Kind of like UWs moral victory over tOSU. They didn't win but it felt good.PostGameOrangeSlices said:
Are you a day trader? No, of course you're notBaseman said:
Did you put all your best customers in it?PostGameOrangeSlices said:
It will be double digits by month end and great for your portfolioBaseman said:
Great news. Just not for my portfolio.PostGameOrangeSlices said:I'll add - the webinar and press release showcased the trial results were good. For treating cancer. If you dont think that is bullish I can't help you.
Ill be sure to bump this thread to gloat.
Moving my picks to Pack the Fudge. I don't like to lose $
If a biotech stock dropping on good news is scary to your wallet then stick with Apple and MSFT -
Yeah because the stock market only takes place one day out of the year and you only get a W or L. Great fucking analogy.Baseman said:
Kind of like UWs moral victory over tOSU. They didn't win but it felt good.PostGameOrangeSlices said:
Are you a day trader? No, of course you're notBaseman said:
Did you put all your best customers in it?PostGameOrangeSlices said:
It will be double digits by month end and great for your portfolioBaseman said:
Great news. Just not for my portfolio.PostGameOrangeSlices said:I'll add - the webinar and press release showcased the trial results were good. For treating cancer. If you dont think that is bullish I can't help you.
Ill be sure to bump this thread to gloat.
Moving my picks to Pack the Fudge. I don't like to lose $
If a biotech stock dropping on good news is scary to your wallet then stick with Apple and MSFT -
Easy turbo. I just bought 500 shares. It better fucking move.PostGameOrangeSlices said:
Yeah because the stock market only takes place one day out of the year and you only get a W or L. Great fucking analogy.Baseman said:
Kind of like UWs moral victory over tOSU. They didn't win but it felt good.PostGameOrangeSlices said:
Are you a day trader? No, of course you're notBaseman said:
Did you put all your best customers in it?PostGameOrangeSlices said:
It will be double digits by month end and great for your portfolioBaseman said:
Great news. Just not for my portfolio.PostGameOrangeSlices said:I'll add - the webinar and press release showcased the trial results were good. For treating cancer. If you dont think that is bullish I can't help you.
Ill be sure to bump this thread to gloat.
Moving my picks to Pack the Fudge. I don't like to lose $
If a biotech stock dropping on good news is scary to your wallet then stick with Apple and MSFT -
Look at you buying the dip. Im like a proud parent right nowBaseman said:
Easy turbo. I just bought 500 shares. It better fucking move.PostGameOrangeSlices said:
Yeah because the stock market only takes place one day out of the year and you only get a W or L. Great fucking analogy.Baseman said:
Kind of like UWs moral victory over tOSU. They didn't win but it felt good.PostGameOrangeSlices said:
Are you a day trader? No, of course you're notBaseman said:
Did you put all your best customers in it?PostGameOrangeSlices said:
It will be double digits by month end and great for your portfolioBaseman said:
Great news. Just not for my portfolio.PostGameOrangeSlices said:I'll add - the webinar and press release showcased the trial results were good. For treating cancer. If you dont think that is bullish I can't help you.
Ill be sure to bump this thread to gloat.
Moving my picks to Pack the Fudge. I don't like to lose $
If a biotech stock dropping on good news is scary to your wallet then stick with Apple and MSFT -
I should also add - June 25 is the date its added to the Russell index
-
Thinking about going all in here. The fellas down at the club have been all atwitter about it. Just what I'm hearing...
https://www.otcmarkets.com/stock/BLIAQ/profile
-
Yea yes retail movie rentals = cancer treatment
I did laugh -
Great tip! Down 10% already!
-
You better sell and realize that loss!Baseman said:Great tip! Down 10% already!
-
Not familiar in ATOS...I do like to dabble in biotechs though. ATOS at $20 would put its market cap at a couple billion...pretty steep for a biotech with Phase 2 results and a pretty limited pipeline:
https://atossatherapeutics.com/product-pipeline/ .
In my limited experience in bios they seem to work in levels...bioturds with <$100M market cap, promising early stage stuff with a market cap of $100MM<$500MM, and then breakthroughs that ramp up to a billion or so have a product that is a bolt-on for the big guys and a likely buyout candidate.
Give you a comparison of one I watch/own...PDSB. It has already run up a bunch but even with that run its only at a $250MM market cap (about half of ATOS), with pretty diverse pipeline and positive interim Phase 2 results:
https://pdsbiotech.com/pipeline/oncology. Those results pushed it from bioturd to promising...will wait and see if they get further along to the breakthrough status.



